{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:28:01Z","timestamp":1787930881425,"version":"build-2784847793"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10787-026-02333-z","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:26:49Z","timestamp":1784266009000},"page":"5093-5117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Resveratrol and neuroprotection: modulation of cellular dynamics and signaling networks in neurodegenerative diseases"],"prefix":"10.1007","volume":"34","author":[{"given":"Md Abul","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Al Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherouk Hussein","family":"Sweilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abohassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthickeyan","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeetendra Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patibandla","family":"Jahnavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwar","family":"Vodeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Radha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem Shankar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konatham Teja Kumar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"3","key":"2333_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.31351\/vol32iss3pp118-127","volume":"32","author":"GM Amin","year":"2023","unstructured":"Amin GM, Marouf BH, Namiq H (2023) The effects of resveratrol supplementation on the quality of life of diabetic patients with neuropathy: small randomized clinical trial. Iraqi J Pharmac Sci 32(3):118\u2013127","journal-title":"Iraqi J Pharmac Sci"},{"issue":"1","key":"2333_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/7739710","volume":"2024","author":"GSM Amin","year":"2024","unstructured":"Amin GSM, Marouf BH, Namiq HS, Salih JM (2024) Impact of resveratrol and pharmaceutical care on type 2 diabetes mellitus and its neuropathic complication: a randomized placebo controlled clinical trial. J Clin Pharm Ther 2024(1):7739710","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"2333_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11010-006-9253-0","volume":"294","author":"O Ates","year":"2007","unstructured":"Ates O et al (2007) Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem 294(1):137\u2013144","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"2333_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"B-I Bae","year":"2005","unstructured":"Bae B-I et al (2005) P53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron 47(1):29\u201341","journal-title":"Neuron"},{"issue":"3","key":"2333_CR5","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/ijms23031047","volume":"23","author":"O Bankole","year":"2022","unstructured":"Bankole O et al (2022) Beneficial and sexually dimorphic response to combined HDAC inhibitor valproate and AMPK\/SIRT1 pathway activator resveratrol in the treatment of ALS mice. Int J Mol Sci 23(3):1047","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2333_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/antiox13020177","volume":"13","author":"C Bartra","year":"2024","unstructured":"Bartra C et al (2024) Resveratrol activates antioxidant protective mechanisms in cellular models of Alzheimer\u2019s disease inflammation. Antioxidants (Basel) 13(2):177","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"2333_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","volume":"52","author":"S Boill\u00e9e","year":"2006","unstructured":"Boill\u00e9e S, Vande Velde C, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52(1):39\u201359","journal-title":"Neuron"},{"issue":"1","key":"2333_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","volume":"27","author":"LI Bruijn","year":"2004","unstructured":"Bruijn LI, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27(1):723\u2013749","journal-title":"Annu Rev Neurosci"},{"issue":"8","key":"2333_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1089\/jmf.2021.0084","volume":"25","author":"DS Buglio","year":"2022","unstructured":"Buglio DS et al (2022) The role of resveratrol in mild cognitive impairment and Alzheimer\u2019s disease: a systematic review. J Med Food 25(8):797\u2013806","journal-title":"J Med Food"},{"issue":"3","key":"2333_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1471-4159.2011.07594.x","volume":"120","author":"H Capiralla","year":"2012","unstructured":"Capiralla H et al (2012) Resveratrol mitigates lipopolysaccharide-and A\u03b2-mediated microglial inflammation by inhibiting the TLR4\/NF-\u03baB\/STAT signaling cascade. J Neurochem 120(3):461\u2013472","journal-title":"J Neurochem"},{"issue":"1","key":"2333_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/nyas.12816","volume":"1348","author":"AS Chauhan","year":"2015","unstructured":"Chauhan AS (2015) Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol. Ann N Y Acad Sci 1348(1):134\u2013140","journal-title":"Ann N Y Acad Sci"},{"key":"2333_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104476","volume":"150","author":"J-Y Chen","year":"2019","unstructured":"Chen J-Y, Zhu Q, Zhang S, OuYang D, Lu J-H (2019) Resveratrol in experimental Alzheimer\u2019s disease models: a systematic review of preclinical studies. Pharmacol Res 150:104476","journal-title":"Pharmacol Res"},{"issue":"5","key":"2333_CR13","first-page":"423","volume":"22","author":"U \u00c7ift\u00e7i","year":"2016","unstructured":"\u00c7ift\u00e7i U et al (2016) Efficiacy of resveratrol and quercetin after experimental spinal cord injury. Ulus Travma Acil Cerrahi Derg 22(5):423\u2013431","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"2333_CR14","unstructured":"Dalal D, Singh L, Singh A (2024) Mechanistic insight unrevealing the potential of Diadzein in ameliorating the Alzheimer\u2019s disease. Front Health Inform 13(3)"},{"issue":"2","key":"2333_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5152\/pcp.2023.23633","volume":"33","author":"B Dan\u0131\u015fman","year":"2023","unstructured":"Dan\u0131\u015fman B, Kelek SE, Aslan M (2023) Resveratrol in neurodegeneration, in neurodegenerative diseases, and in the redox biology of the mitochondria. Psychiatry Clin Psychopharmacol 33(2):147","journal-title":"Psychiatry Clin Psychopharmacol"},{"issue":"3","key":"2333_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11523","volume":"24","author":"Z-B Dong","year":"2022","unstructured":"Dong Z-B et al (2022) Resveratrol ameliorates oxaliplatin-induced neuropathic pain via anti-inflammatory effects in rats. Exp Ther Med 24(3):1\u201310","journal-title":"Exp Ther Med"},{"issue":"5","key":"2333_CR17","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1523\/JNEUROSCI.23-05-01688.2003","volume":"23","author":"J Dunlop","year":"2003","unstructured":"Dunlop J, McIlvain HB, She Y, Howland DS (2003) Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. J Neurosci 23(5):1688\u20131696","journal-title":"J Neurosci"},{"issue":"3","key":"2333_CR18","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1007\/s12035-024-04415-x","volume":"62","author":"SA El-Sayed","year":"2025","unstructured":"El-Sayed SA, Fouad GI, Rizk MZ, Beherei HH, Mabrouk M (2025) Comparative neuroprotective potential of nanoformulated and free resveratrol against cuprizone-induced demyelination in rats. Mol Neurobiol 62(3):2710\u20132725","journal-title":"Mol Neurobiol"},{"issue":"3","key":"2333_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059888","volume":"8","author":"X Feng","year":"2013","unstructured":"Feng X et al (2013) Resveratrol inhibits \u03b2-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway. PLoS ONE 8(3):e59888","journal-title":"PLoS ONE"},{"issue":"4","key":"2333_CR20","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3892\/ijmm.2016.2495","volume":"37","author":"Y Feng","year":"2016","unstructured":"Feng Y et al (2016) Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4\/NF-\u03baB signaling pathway in experimental traumatic brain injury. Int J Mol Med 37(4):921\u2013930","journal-title":"Int J Mol Med"},{"issue":"2","key":"2333_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5114\/fn.2022.118184","volume":"60","author":"Y Feng","year":"2022","unstructured":"Feng Y et al (2022) Resveratrol attenuates autophagy and inflammation after traumatic brain injury by activation of PI3K\/Akt\/mTOR pathway in rats. Folia Neuropathol 60(2):153\u2013164","journal-title":"Folia Neuropathol"},{"issue":"6","key":"2333_CR22","doi-asserted-by":"publisher","first-page":"6636","DOI":"10.1007\/s12035-024-04234-0","volume":"62","author":"S Feng","year":"2025","unstructured":"Feng S et al (2025) Resveratrol inhibits VDAC1-mediated mitochondrial dysfunction to mitigate pathological progression in Parkinson\u2019s disease model. Mol Neurobiol 62(6):6636\u20136654","journal-title":"Mol Neurobiol"},{"issue":"7","key":"2333_CR23","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.bbadis.2014.02.010","volume":"1842","author":"A Ferretta","year":"1842","unstructured":"Ferretta A et al (1842) Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson\u2019s disease. Biochim Et Biophys Acta (BBA) Mol Basis Dis 1842(7):902\u2013915","journal-title":"Biochim Et Biophys Acta (BBA) Mol Basis Dis"},{"key":"2333_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fneur.2012.00084","volume":"3","author":"Z Fonseca-Kelly","year":"2012","unstructured":"Fonseca-Kelly Z et al (2012) Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front Neurol 3:84","journal-title":"Front Neurol"},{"issue":"2","key":"2333_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.sjbs.2016.10.019","volume":"25","author":"S Fu","year":"2018","unstructured":"Fu S, Lv R, Wang L, Hou H, Liu H, Shao S (2018) Resveratrol, an antioxidant, protects spinal cord injury in rats by suppressing MAPK pathway. Saudi J Biol Sci 25(2):259\u2013266","journal-title":"Saudi J Biol Sci"},{"issue":"5","key":"2333_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.freeradbiomed.2010.06.002","volume":"49","author":"M Fukui","year":"2010","unstructured":"Fukui M, Choi HJ, Zhu BT (2010) Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic Biol Med 49(5):800\u2013813","journal-title":"Free Radic Biol Med"},{"key":"2333_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cbi.2016.03.023","volume":"251","author":"HH Gaballah","year":"2016","unstructured":"Gaballah HH, Zakaria SS, Elbatsh MM, Tahoon NM (2016) Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson\u2019s disease. Chem Biol Interact 251:10\u201316","journal-title":"Chem Biol Interact"},{"issue":"3","key":"2333_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s11481-019-09842-5","volume":"14","author":"KAO Gandy","year":"2019","unstructured":"Gandy KAO, Zhang J, Nagarkatti P, Nagarkatti M (2019) Resveratrol (3, 5, 4\u2032-trihydroxy-trans-stilbene) attenuates a mouse model of multiple sclerosis by altering the miR-124\/sphingosine kinase 1 axis in encephalitogenic T cells in the brain. J Neuroimmune Pharmacol 14(3):462\u2013477","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"2333_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/TA.0b013e31827e1f51","volume":"74","author":"JW Gatson","year":"2013","unstructured":"Gatson JW et al (2013) Resveratrol decreases inflammation in the brain of mice with mild traumatic brain injury. J Trauma Acute Care Surg 74(2):470\u2013475","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"2333_CR30","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1007\/s12035-016-9891-5","volume":"54","author":"HR Ghaiad","year":"2017","unstructured":"Ghaiad HR, Nooh MM, El-Sawalhi MM, Shaheen AA (2017) Resveratrol promotes remyelination in cuprizone model of multiple sclerosis: biochemical and histological study. Mol Neurobiol 54(5):3219\u20133229","journal-title":"Mol Neurobiol"},{"key":"2333_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2023.102014","volume":"81","author":"RE Ghoweba","year":"2023","unstructured":"Ghoweba RE, Khowailed AA, Aboulhoda BE, Rashed LA, Selmy A (2023) Synergistic role of resveratrol and exercise training in management of diabetic neuropathy and myopathy via SIRT1\/NGF\/GAP43 linkage. Tissue Cell 81:102014","journal-title":"Tissue Cell"},{"issue":"1","key":"2333_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8152373","volume":"2018","author":"BAQ Gomes","year":"2018","unstructured":"Gomes BAQ et al (2018) Neuroprotective mechanisms of resveratrol in Alzheimer\u2019s disease: role of SIRT1. Oxid Med Cell Longev 2018(1):8152373","journal-title":"Oxid Med Cell Longev"},{"key":"2333_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106377","volume":"183","author":"N He","year":"2022","unstructured":"He N et al (2022) Resveratrol suppresses microglial activation and promotes functional recovery of traumatic spinal cord via improving intestinal microbiota. Pharmacol Res 183:106377","journal-title":"Pharmacol Res"},{"issue":"1","key":"2333_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","volume":"225","author":"DJ Ho","year":"2010","unstructured":"Ho DJ, Calingasan NY, Wille E, Dumont M, Beal MF (2010) Resveratrol protects against peripheral deficits in a mouse model of Huntington\u2019s disease. Exp Neurol 225(1):74\u201384","journal-title":"Exp Neurol"},{"issue":"10","key":"2333_CR35","first-page":"4607","volume":"9","author":"J Hu","year":"2017","unstructured":"Hu J et al (2017) Resveratrol improves neuron protection and functional recovery through enhancement of autophagy after spinal cord injury in mice. Am J Transl Res 9(10):4607","journal-title":"Am J Transl Res"},{"issue":"5","key":"2333_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3892\/br.2016.630","volume":"4","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Zhang X, Chen WW (2016) Role of oxidative stress in Alzheimer\u2019s disease. Biomed Rep 4(5):519\u2013522","journal-title":"Biomed Rep"},{"key":"2333_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108552","volume":"88","author":"J Huang","year":"2021","unstructured":"Huang J et al (2021) Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases. J Nutr Biochem 88:108552","journal-title":"J Nutr Biochem"},{"issue":"2","key":"2333_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jgr.2018.01.001","volume":"43","author":"M Jakaria","year":"2019","unstructured":"Jakaria M, Kim J, Karthivashan G, Park S-Y, Ganesan P, Choi D-K (2019) Emerging signals modulating potential of ginseng and its active compounds focusing on neurodegenerative diseases. J Ginseng Res 43(2):163\u2013171","journal-title":"J Ginseng Res"},{"key":"2333_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2016.04.007","volume":"44","author":"SI Jeong","year":"2016","unstructured":"Jeong SI et al (2016) Resveratrol attenuates peripheral and brain inflammation and reduces ischemic brain injury in aged female mice. Neurobiol Aging 44:74\u201384","journal-title":"Neurobiol Aging"},{"issue":"1\u20133","key":"2333_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","volume":"600","author":"F Jin","year":"2008","unstructured":"Jin F, Wu Q, Lu Y-F, Gong Q-H, Shi J-S (2008) Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson\u2019s disease in rats. Eur J Pharmacol 600(1\u20133):78\u201382","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"2333_CR41","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1016\/j.athoracsur.2005.05.016","volume":"80","author":"S Kaplan","year":"2005","unstructured":"Kaplan S, Bisleri G, Morgan JA, Cheema FH, Oz MC (2005) Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion\u2013induced spinal cord injury. Ann Thorac Surg 80(6):2242\u20132249","journal-title":"Ann Thorac Surg"},{"issue":"19","key":"2333_CR42","doi-asserted-by":"publisher","first-page":"7774","DOI":"10.1073\/pnas.0902505106","volume":"106","author":"CM Karch","year":"2009","unstructured":"Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR (2009) Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci USA 106(19):7774\u20137779","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2333_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","volume":"54","author":"SS Karuppagounder","year":"2009","unstructured":"Karuppagounder SS, Pinto JT, Xu H, Chen H-L, Beal MF, Gibson GE (2009) Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer\u2019s disease. Neurochem Int 54(2):111\u2013118","journal-title":"Neurochem Int"},{"issue":"7","key":"2333_CR44","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1080\/1028415X.2024.2425649","volume":"28","author":"S Keramatzadeh","year":"2025","unstructured":"Keramatzadeh S, Hosseini SA, Majdinasab N, Cheraghian B, Zilaee M (2025) Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial. Nutr Neurosci 28(7):854\u2013862","journal-title":"Nutr Neurosci"},{"key":"2333_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2010.02.031","volume":"1328","author":"MM Khan","year":"2010","unstructured":"Khan MM et al (2010) Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson\u2019s disease. Brain Res 1328:139\u2013151","journal-title":"Brain Res"},{"issue":"2","key":"2333_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.advms.2020.08.002","volume":"65","author":"J Komorowska","year":"2020","unstructured":"Komorowska J, W\u0105troba M, Szukiewicz D (2020) Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer\u2019s disease. Adv Med Sci 65(2):415\u2013423","journal-title":"Adv Med Sci"},{"key":"2333_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8983752","author":"D Kong","year":"2019","unstructured":"Kong D et al (2019) Effects of resveratrol on the mechanisms of antioxidants and estrogen in Alzheimer\u2019s disease. BioMed Res Int. https:\/\/doi.org\/10.1155\/2019\/8983752","journal-title":"BioMed Res Int"},{"issue":"2","key":"2333_CR48","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bbrc.2010.03.014","volume":"394","author":"A Kumar","year":"2010","unstructured":"Kumar A, Sharma SS (2010) NF-\u03baB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem Biophys Res Commun 394(2):360\u2013365","journal-title":"Biochem Biophys Res Commun"},{"issue":"5-6","key":"2333_CR49","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00008877-200609000-00014","volume":"17","author":"P Kumar","year":"2006","unstructured":"Kumar P, Padi SSV, Naidu PS, Kumar A (2006) Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 17(5\u20136):485\u2013492","journal-title":"Behav Pharmacol"},{"issue":"3","key":"2333_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1472-8206.2007.00485.x","volume":"21","author":"P Kumar","year":"2007","unstructured":"Kumar P, Padi S, Naidu P, Kumar A (2007a) Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms. Fundam Clin Pharmacol 21(3):297\u2013306","journal-title":"Fundam Clin Pharmacol"},{"issue":"13","key":"2333_CR51","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.lfs.2006.12.036","volume":"80","author":"A Kumar","year":"2007","unstructured":"Kumar A, Kaundal RK, Iyer S, Sharma SS (2007b) Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci 80(13):1236\u20131244","journal-title":"Life Sci"},{"issue":"8","key":"2333_CR52","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/biomedicines9080918","volume":"9","author":"H-C Kung","year":"2021","unstructured":"Kung H-C, Lin K-J, Kung C-T, Lin T-K (2021) Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson\u2019s disease. Biomedicines 9(8):918","journal-title":"Biomedicines"},{"key":"2333_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105779","volume":"75","author":"K Le","year":"2019","unstructured":"Le K et al (2019) SIRT1-regulated HMGB1 release is partially involved in TLR4 signal transduction: a possible anti-neuroinflammatory mechanism of resveratrol in neonatal hypoxic-ischemic brain injury. Int Immunopharmacol 75:105779","journal-title":"Int Immunopharmacol"},{"key":"2333_CR54","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2147\/JPR.S185873","volume":"4","author":"X Li","year":"2019","unstructured":"Li X et al (2019) Resveratrol inhibits paclitaxel-induced neuropathic pain by the activation of PI3K\/Akt and SIRT1\/PGC1\u03b1 pathway. J Pain Res 4:879\u2013890","journal-title":"J Pain Res"},{"issue":"1","key":"2333_CR55","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2174206","volume":"30","author":"C Li","year":"2023","unstructured":"Li C, Wang Z, Lei H, Zhang D (2023) Recent progress in nanotechnology-based drug carriers for resveratrol delivery. Drug Deliv 30(1):2174206","journal-title":"Drug Deliv"},{"key":"2333_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.brainres.2010.11.061","volume":"1374","author":"C Liu","year":"2011","unstructured":"Liu C, Shi Z, Fan L, Zhang C, Wang K, Wang B (2011) Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res 1374:100\u2013109","journal-title":"Brain Res"},{"issue":"2","key":"2333_CR57","first-page":"1237","volume":"8","author":"J Liu","year":"2015","unstructured":"Liu J, Yi L, Xiang Z, Zhong J, Zhang H, Sun T (2015) Resveratrol attenuates spinal cord injury-induced inflammatory damage in rat lungs. Int J Clin Exp Pathol 8(2):1237","journal-title":"Int J Clin Exp Pathol"},{"key":"2333_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbr.2019.03.043","volume":"367","author":"Q Liu","year":"2019","unstructured":"Liu Q et al (2019) Resveratrol synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson disease in mice. Behav Brain Res 367:10\u201318","journal-title":"Behav Brain Res"},{"issue":"3","key":"2333_CR59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1753425913488429","volume":"20","author":"DD Lofrumento","year":"2014","unstructured":"Lofrumento DD et al (2014) Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson\u2019s-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses. Innate Immun 20(3):249\u2013260","journal-title":"Innate Immun"},{"issue":"16","key":"2333_CR60","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1021\/jf8007212","volume":"56","author":"K-T Lu","year":"2008","unstructured":"Lu K-T et al (2008) Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 56(16):6910\u20136913","journal-title":"J Agric Food Chem"},{"issue":"2","key":"2333_CR61","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","volume":"107","author":"J Luo","year":"2001","unstructured":"Luo J et al (2001) Negative control of p53 by Sir2\u03b1 promotes cell survival under stress. Cell 107(2):137\u2013148","journal-title":"Cell"},{"key":"2333_CR62","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3389\/fnins.2019.01400","volume":"13","author":"X Ma","year":"2020","unstructured":"Ma X et al (2020) Neuroprotective effect of resveratrol via activation of Sirt1 signaling in a rat model of combined diabetes and Alzheimer\u2019s disease. Front Neurosci 13:1400","journal-title":"Front Neurosci"},{"issue":"3","key":"2333_CR63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/neurosci2030022","volume":"2","author":"ND Machado","year":"2021","unstructured":"Machado ND, Armas GV, Fern\u00e1ndez MA, Grijalvo S, D\u00edaz D\u00edaz D (2021) Neuroprotective effects of resveratrol in ischemic brain injury. NeuroSci 2(3):305\u2013319","journal-title":"NeuroSci"},{"issue":"2","key":"2333_CR64","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s13311-013-0253-y","volume":"11","author":"R Mancuso","year":"2014","unstructured":"Mancuso R et al (2014) Resveratrol improves motoneuron function and extends survival in SOD1G93A ALS mice. Neurotherapeutics 11(2):419\u2013432","journal-title":"Neurotherapeutics"},{"issue":"45","key":"2333_CR65","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.1074\/jbc.M508246200","volume":"280","author":"P Marambaud","year":"2005","unstructured":"Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-\u03b2 peptides. J Biol Chem 280(45):37377\u201337382","journal-title":"J Biol Chem"},{"issue":"5","key":"2333_CR66","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1089\/jmf.2009.0243","volume":"13","author":"CD Markert","year":"2010","unstructured":"Markert CD, Kim E, Gifondorwa DJ, Childers MK, Milligan CE (2010) A single-dose resveratrol treatment in a mouse model of amyotrophic lateral sclerosis. J Med Food 13(5):1081\u20131085","journal-title":"J Med Food"},{"issue":"4","key":"2333_CR67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/ph18040497","volume":"18","author":"J Mart\u00edn-Ruiz","year":"2025","unstructured":"Mart\u00edn-Ruiz J et al (2025) Enhanced acute muscle activation in ALS patients following liposomal curcumin, resveratrol, and dutasteride administration. Pharmaceuticals (Basel) 18(4):497","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"2333_CR68","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10863-011-9348-5","volume":"43","author":"FJ Miana-Mena","year":"2011","unstructured":"Miana-Mena FJ et al (2011) Levels of membrane fluidity in the spinal cord and the brain in an animal model of amyotrophic lateral sclerosis. J Bioenerg Biomembr 43(2):181\u2013186","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"2333_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","volume":"14","author":"C Moussa","year":"2017","unstructured":"Moussa C et al (2017) Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease. J Neuroinflammation 14(1):1","journal-title":"J Neuroinflammation"},{"key":"2333_CR70","doi-asserted-by":"publisher","first-page":"1059743","DOI":"10.3389\/fneur.2022.1059743","volume":"13","author":"JA Nagy","year":"2022","unstructured":"Nagy JA, Semple C, Lo P, Rutkove SB (2022) Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography. Front Neurol 13:1059743","journal-title":"Front Neurol"},{"issue":"7","key":"2333_CR71","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1007\/s12035-016-0048-3","volume":"54","author":"L Naia","year":"2017","unstructured":"Naia L et al (2017) Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in Huntington\u2019s disease models. Mol Neurobiol 54(7):5385\u20135399","journal-title":"Mol Neurobiol"},{"key":"2333_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.dscb.2022.100038","volume":"6","author":"J Nath","year":"2022","unstructured":"Nath J et al (2022) Resveratrol as a therapeutic choice for traumatic brain injury: an insight into its molecular mechanism of action. Brain Disorders 6:100038","journal-title":"Brain Disorders"},{"issue":"10","key":"2333_CR73","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/jemt.24335","volume":"86","author":"C Ni","year":"2023","unstructured":"Ni C et al (2023) Resveratrol inhibits ferroptosis via activating NRF2\/GPX4 pathway in mice with spinal cord injury. Microsc Res Tech 86(10):1378\u20131390","journal-title":"Microsc Res Tech"},{"issue":"9","key":"2333_CR74","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1007\/s12035-024-04311-4","volume":"61","author":"H\u00d6 Osmanl\u0131o\u011flu","year":"2024","unstructured":"Osmanl\u0131o\u011flu H\u00d6, Naz\u0131ro\u011flu M (2024) Resveratrol modulates diabetes-induced neuropathic pain, apoptosis, and oxidative neurotoxicity in mice through TRPV4 channel inhibition. Mol Neurobiol 61(9):7269\u20137286","journal-title":"Mol Neurobiol"},{"key":"2333_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2026.115639","author":"E Paldino","year":"2026","unstructured":"Paldino E et al (2026) Daily intranasal resveratrol-conjugated gold nanoparticles administration promotes neuroprotection and improves neurological outcome in the R6\/2 mouse model of Huntington\u2019s disease. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2026.115639","journal-title":"Exp Neurol"},{"issue":"1","key":"2333_CR76","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/156720209787466019","volume":"6","author":"M Pall\u00e0s","year":"2009","unstructured":"Pall\u00e0s M et al (2009) Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr Neurovasc Res 6(1):70\u201381","journal-title":"Curr Neurovasc Res"},{"issue":"1","key":"2333_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1573395514666171226154300","volume":"14","author":"A Paloma Soto-Brambila","year":"2018","unstructured":"Paloma Soto-Brambila A, Gabriel Ortiz G, Rivero-Moragrega P, Laura Briones-Torres A, Gonzalez-Ortiz LJ, Pacheco-Moises FP (2018) Relapsing remitting multiple sclerosis and its relationship with the immune system and oxidative stress. Curr Immunol Rev 14(1):15\u201323","journal-title":"Curr Immunol Rev"},{"issue":"8","key":"2333_CR78","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/1440-1681.13105","volume":"46","author":"PT Pan","year":"2019","unstructured":"Pan PT et al (2019) Resveratrol alleviates nuclear factor\u2010\u03baB\u2010mediated neuroinflammation in vasculitic peripheral neuropathy induced by ischaemia\u2013reperfusion via suppressing endoplasmic reticulum stress. Clin Exp Pharmacol Physiol 46(8):770\u2013779","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"2333_CR79","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1517\/17425247.2014.919253","volume":"11","author":"R Pangeni","year":"2014","unstructured":"Pangeni R, Sahni JK, Ali J, Sharma S, Baboota S (2014) Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin Drug Deliv 11(8):1285\u20131298","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"2333_CR80","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/ng1534","volume":"37","author":"JA Parker","year":"2005","unstructured":"Parker JA et al (2005) Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 37(4):349\u2013350","journal-title":"Nat Genet"},{"key":"2333_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1017364","volume":"13","author":"E Parrella","year":"2022","unstructured":"Parrella E et al (2022) Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis. Front Pharmacol 13:1017364","journal-title":"Front Pharmacol"},{"issue":"1","key":"2333_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2011.08.014","volume":"232","author":"GM Pasinetti","year":"2011","unstructured":"Pasinetti GM et al (2011) Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington\u2019s disease and other neurodegenerative disorders. Exp Neurol 232(1):1\u20136","journal-title":"Exp Neurol"},{"issue":"4","key":"2333_CR83","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng C, Trojanowski JQ, Lee VM-Y (2020) Protein transmission in neurodegenerative disease. Nat Rev Neurol 16(4):199\u2013212","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2333_CR84","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3233\/JAD-140444","volume":"42","author":"D Porquet","year":"2014","unstructured":"Porquet D et al (2014) Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer\u2019s disease. J Alzheimers Dis 42(4):1209\u20131220","journal-title":"J Alzheimers Dis"},{"issue":"17","key":"2333_CR85","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1093\/hmg\/ddp260","volume":"18","author":"M Prudencio","year":"2009","unstructured":"Prudencio M, Hart PJ, Borchelt DR, Andersen PM (2009) Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum Mol Genet 18(17):3217\u20133226","journal-title":"Hum Mol Genet"},{"issue":"15","key":"2333_CR86","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.3390\/nu17152557","volume":"17","author":"N Puranik","year":"2025","unstructured":"Puranik N, Kumari M, Tiwari S, Dhakal T, Song M (2025) Resveratrol as a therapeutic agent in Alzheimer\u2019s disease: evidence from clinical studies. Nutrients 17(15):2557","journal-title":"Nutrients"},{"issue":"4","key":"2333_CR87","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12017-008-8044-z","volume":"10","author":"PH Reddy","year":"2008","unstructured":"Reddy PH (2008) Mitochondrial medicine for aging and neurodegenerative diseases. NeuroMol Med 10(4):291\u2013315","journal-title":"NeuroMol Med"},{"issue":"S1","key":"2333_CR88","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.21543","volume":"65","author":"JD Rothstein","year":"2009","unstructured":"Rothstein JD (2009) Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65(S1):S3\u2013S9","journal-title":"Ann Neurol"},{"issue":"22","key":"2333_CR89","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","volume":"344","author":"LP Rowland","year":"2001","unstructured":"Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344(22):1688\u20131700","journal-title":"N Engl J Med"},{"key":"2333_CR90","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.colsurfb.2019.04.030","volume":"180","author":"AC Santos","year":"2019","unstructured":"Santos AC et al (2019) Nanotechnology-based formulations for resveratrol delivery: effects on resveratrol in vivo bioavailability and bioactivity. Colloids Surf B Biointerfaces 180:127\u2013140","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"2333_CR91","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.ajpath.2013.07.006","volume":"183","author":"F Sato","year":"2013","unstructured":"Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda I (2013) Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol 183(5):1390\u20131396","journal-title":"Am J Pathol"},{"key":"2333_CR92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.20200255","author":"E Shamsher","year":"2021","unstructured":"Shamsher E et al (2021) Resveratrol nanoparticles are neuroprotective in a model of multiple sclerosis. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/j.1755-3768.20200255","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"2333_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25074047","volume":"25","author":"E Shamsher","year":"2024","unstructured":"Shamsher E et al (2024a) Intranasal resveratrol nanoparticles enhance neuroprotection in a model of multiple sclerosis. Int J Mol Sci 25(7):4047","journal-title":"Int J Mol Sci"},{"key":"2333_CR94","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15821","author":"E Shamsher","year":"2024","unstructured":"Shamsher E et al (2024b) Effects of oral and intranasal resveratrol nanoparticle administration on neurodegeneration and neuronal dysfunction in a model of multiple sclerosis. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.15821","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"2333_CR95","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1472-8206.2006.00455.x","volume":"21","author":"S Sharma","year":"2007","unstructured":"Sharma S, Kulkarni SK, Chopra K (2007a) Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundam Clin Pharmacol 21(1):89\u201394","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"2333_CR96","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ptr.2070","volume":"21","author":"S Sharma","year":"2007","unstructured":"Sharma S, Chopra K, Kulkarni SK (2007b) Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res 21(3):278\u2013283","journal-title":"Phytother Res"},{"key":"2333_CR97","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.12659\/MSM.909042","volume":"24","author":"Z Shi","year":"2018","unstructured":"Shi Z, Qiu W, Xiao G, Cheng J, Zhang N (2018) Resveratrol attenuates cognitive deficits of traumatic brain injury by activating p38 signaling in the brain. Med Sci Monit 24:1097","journal-title":"Med Sci Monit"},{"issue":"4","key":"2333_CR98","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","volume":"30","author":"KS Shindler","year":"2010","unstructured":"Shindler KS, Ventura E, Dutt M, Elliott P, Fitzgerald DC, Rostami A (2010) Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol 30(4):328\u2013339","journal-title":"J Neuroophthalmol"},{"issue":"8","key":"2333_CR99","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"A Singh","year":"2019","unstructured":"Singh A, Kukreti R, Saso L, Kukreti S (2019) Oxidative stress: a key modulator in neurodegenerative diseases. Molecules 24(8):1583","journal-title":"Molecules"},{"issue":"1","key":"2333_CR100","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s40473-026-00324-6","volume":"13","author":"A Singh","year":"2026","unstructured":"Singh A, Singh L, Dalal D (2026a) From bench to bedside: unveiling the effects of anatabine as a promising neuroprotective agent in the battle against neurodegenerative disorders. Curr Behav Neurosci Rep 13(1):6","journal-title":"Curr Behav Neurosci Rep"},{"issue":"1","key":"2333_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40473-026-00319-3","volume":"13","author":"A Singh","year":"2026","unstructured":"Singh A, Singh L, Dalal D (2026b) Mechanistic insights into the therapeutic potential of apigenin in Parkinson\u2019s disease: an in silico docking and ADMET study. Curr Behav Neurosci Rep 13(1):1","journal-title":"Curr Behav Neurosci Rep"},{"issue":"6","key":"2333_CR102","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1089\/neu.2010.1291","volume":"27","author":"RH Singleton","year":"2010","unstructured":"Singleton RH, Yan HQ, Fellows-Mayle W, Dixon CE (2010) Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury. J Neurotrauma 27(6):1091\u20131099","journal-title":"J Neurotrauma"},{"issue":"2","key":"2333_CR103","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neulet.2007.04.070","volume":"420","author":"\u00dc S\u00f6nmez","year":"2007","unstructured":"S\u00f6nmez \u00dc, S\u00f6nmez A, Erbil G, Tekmen I, Baykara B (2007) Neuroprotective effects of resveratrol against traumatic brain injury in immature rats. Neurosci Lett 420(2):133\u2013137","journal-title":"Neurosci Lett"},{"key":"2333_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.644219","volume":"12","author":"C-F Su","year":"2021","unstructured":"Su C-F, Jiang L, Zhang X-W, Iyaswamy A, Li M (2021) Resveratrol in rodent models of Parkinson\u2019s disease: a systematic review of experimental studies. Front Pharmacol 12:644219","journal-title":"Front Pharmacol"},{"issue":"4","key":"2333_CR105","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12017-008-8052-z","volume":"10","author":"AY Sun","year":"2008","unstructured":"Sun AY, Wang Q, Simonyi A, Sun GY (2008) Botanical phenolics and brain health. Neuromol Med 10(4):259\u2013274","journal-title":"Neuromol Med"},{"key":"2333_CR106","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.freeradbiomed.2014.07.034","volume":"75","author":"N Tamaki","year":"2014","unstructured":"Tamaki N, Orihuela-Campos RC, Inagaki Y, Fukui M, Nagata T, Ito H-O (2014) Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1\/AMPK and the Nrf2\/antioxidant defense pathways in a rat periodontitis model. Free Radic Biol Med 75:222\u2013229","journal-title":"Free Radic Biol Med"},{"key":"2333_CR107","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.intimp.2016.02.033","volume":"34","author":"L Tao","year":"2016","unstructured":"Tao L, Ding Q, Gao C, Sun X (2016) Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice. Int Immunopharmacol 34:165\u2013172","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"2333_CR108","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1039\/D2FO03379H","volume":"14","author":"J Tao","year":"2023","unstructured":"Tao J et al (2023) The protective role of microbiota in the prevention of MPTP\/P-induced Parkinson\u2019s disease by resveratrol. Food Funct 14(10):4647\u20134661","journal-title":"Food Funct"},{"issue":"4","key":"2333_CR109","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1134\/S0022093022040093","volume":"58","author":"M Tecellio\u011flu","year":"2022","unstructured":"Tecellio\u011flu M et al (2022) The beneficial effects of resveratrol on experimental autoimmune encephalomyelitis (EAE) in C57BL\/6J mouse model. J Evol Biochem Physiol 58(4):1041\u20131054","journal-title":"J Evol Biochem Physiol"},{"issue":"2","key":"2333_CR110","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jvs.2007.04.044","volume":"46","author":"S-K Tsai","year":"2007","unstructured":"Tsai S-K et al (2007) Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg 46(2):346\u2013353","journal-title":"J Vasc Surg"},{"issue":"16","key":"2333_CR111","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","volume":"85","author":"RS Turner","year":"2015","unstructured":"Turner RS et al (2015) A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85(16):1383\u20131391","journal-title":"Neurology"},{"issue":"5","key":"2333_CR112","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1007\/s12035-024-04608-4","volume":"62","author":"BK Utpal","year":"2025","unstructured":"Utpal BK et al (2025) Resveratrol: a natural compound targeting the PI3K\/Akt\/mTOR pathway in neurological diseases. Mol Neurobiol 62(5):5579\u20135608","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2333_CR113","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","volume":"107","author":"H Vaziri","year":"2001","unstructured":"Vaziri H et al (2001) hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase. Cell 107(2):149\u2013159","journal-title":"Cell"},{"key":"2333_CR114","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuint.2017.05.013","volume":"117","author":"C Vidoni","year":"2018","unstructured":"Vidoni C, Secomandi E, Castiglioni A, Melone MA, Isidoro C (2018) Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation. Neurochem Int 117:174\u2013187","journal-title":"Neurochem Int"},{"issue":"5","key":"2333_CR115","doi-asserted-by":"publisher","first-page":"362","DOI":"10.37349\/en.2024.00055","volume":"3","author":"PH Villar-Delfino","year":"2024","unstructured":"Villar-Delfino PH, Santos RP, Christo PP, Nogueira-Machado JA, Volpe CMO (2024) Antioxidant effects of resveratrol in granulocytes from multiple sclerosis patients. Explor Neurosci 3(5):362\u2013374","journal-title":"Explor Neurosci"},{"issue":"3","key":"2333_CR116","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neulet.2011.08.047","volume":"503","author":"J Wang","year":"2011","unstructured":"Wang J, Zhang Y, Tang L, Zhang N, Fan D (2011) Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis. Neurosci Lett 503(3):250\u2013255","journal-title":"Neurosci Lett"},{"issue":"4","key":"2333_CR117","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/bph.12301","volume":"170","author":"HD Wang","year":"2013","unstructured":"Wang HD, Shi YM, Li L, Guo JD, Zhang YP, Hou SX (2013) Treatment with resveratrol attenuates sublesional bone loss in spinal cord-injured rats. Br J Pharmacol 170(4):796\u2013806","journal-title":"Br J Pharmacol"},{"key":"2333_CR118","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.biopha.2015.08.025","volume":"74","author":"Z-H Wang","year":"2015","unstructured":"Wang Z-H, Zhang J-L, Duan Y-L, Zhang Q-S, Li G-F, Zheng D-L (2015) MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting \u03b1-synuclein expression in MPTP-induced Parkinson\u2019s disease mouse. Biomed Pharmacother 74:252\u2013256","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2333_CR119","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1152\/jn.00510.2016","volume":"116","author":"D Wang","year":"2016","unstructured":"Wang D, Li S-P, Fu J-S, Zhang S, Bai L, Guo L (2016) Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice. J Neurophysiol 116(5):2173\u20132179","journal-title":"J Neurophysiol"},{"key":"2333_CR120","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.toxlet.2017.10.021","volume":"282","author":"H Wang","year":"2018","unstructured":"Wang H, Jiang T, Li W, Gao N, Zhang T (2018a) Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer\u2019s disease. Toxicol Lett 282:100\u2013108","journal-title":"Toxicol Lett"},{"key":"2333_CR121","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbr.2017.10.032","volume":"339","author":"X Wang","year":"2018","unstructured":"Wang X et al (2018b) Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer\u2019s disease. Behav Brain Res 339:297\u2013304","journal-title":"Behav Brain Res"},{"issue":"12","key":"2333_CR122","doi-asserted-by":"publisher","first-page":"17124","DOI":"10.1021\/acssuschemeng.8b04507","volume":"6","author":"M Wang","year":"2018","unstructured":"Wang M et al (2018c) Magnetic resveratrol liposomes as a new theranostic platform for magnetic resonance imaging guided Parkinson\u2019s disease targeting therapy. ACS Sustain Chem Eng 6(12):17124\u201317133","journal-title":"ACS Sustain Chem Eng"},{"issue":"9","key":"2333_CR123","doi-asserted-by":"publisher","first-page":"8427","DOI":"10.18632\/oncotarget.23877","volume":"9","author":"P Wang","year":"2018","unstructured":"Wang P et al (2018d) Resveratrol ameliorates autophagic flux to promote functional recovery in rats after spinal cord injury. Oncotarget 9(9):8427","journal-title":"Oncotarget"},{"issue":"10","key":"2333_CR124","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.18632\/aging.101966","volume":"11","author":"N Wang","year":"2019","unstructured":"Wang N et al (2019a) Exploration of age-related mitochondrial dysfunction and the anti-aging effects of resveratrol in zebrafish retina. Aging 11(10):3117","journal-title":"Aging"},{"issue":"5","key":"2333_CR125","first-page":"3555","volume":"17","author":"C Wang","year":"2019","unstructured":"Wang C et al (2019b) The combined effect of mesenchymal stem cells and resveratrol on type 1 diabetic neuropathy. Exp Ther Med 17(5):3555\u20133563","journal-title":"Exp Ther Med"},{"issue":"1","key":"2333_CR126","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbrc.2012.08.045","volume":"426","author":"RD Wight","year":"2012","unstructured":"Wight RD et al (2012) Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases. Biochem Biophys Res Commun 426(1):112\u2013115","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2333_CR127","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000328516","volume":"19","author":"Y Wu","year":"2011","unstructured":"Wu Y et al (2011) Resveratrol-activated AMPK\/SIRT1\/autophagy in cellular models of Parkinson\u2019s disease. Neurosignals 19(3):163\u2013174","journal-title":"Neurosignals"},{"issue":"4","key":"2333_CR128","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1002\/jcb.27769","volume":"120","author":"D Xia","year":"2019","unstructured":"Xia D, Sui R, Zhang Z (2019) Administration of resveratrol improved Parkinson\u2019s disease-like phenotype by suppressing apoptosis of neurons via modulating the MALAT1\/miR-129\/SNCA signaling pathway. J Cell Biochem 120(4):4942\u20134951","journal-title":"J Cell Biochem"},{"issue":"1","key":"2333_CR129","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/JHD-130046","volume":"2","author":"Z Xiang","year":"2013","unstructured":"Xiang Z, Krainc D (2013) Pharmacological upregulation of PGC1\u03b1 in oligodendrocytes: implications for Huntington\u2019s disease. J Huntington Dis 2(1):101\u2013105","journal-title":"J Huntington Dis"},{"issue":"20","key":"2333_CR130","doi-asserted-by":"publisher","first-page":"23603","DOI":"10.18632\/aging.203628","volume":"13","author":"Z Xiang","year":"2021","unstructured":"Xiang Z et al (2021) Resveratrol promotes axonal regeneration after spinal cord injury through activating Wnt\/\u03b2-catenin signaling pathway. Aging 13(20):23603","journal-title":"Aging"},{"issue":"10","key":"2333_CR131","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.4103\/1673-5374.257529","volume":"14","author":"Y-K Xie","year":"2019","unstructured":"Xie Y-K et al (2019) Resveratrol reduces brain injury after subarachnoid hemorrhage by inhibiting oxidative stress and endoplasmic reticulum stress. Neural Regen Res 14(10):1734\u20131742","journal-title":"Neural Regen Res"},{"key":"2333_CR132","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3389\/fnins.2018.00690","volume":"12","author":"L Xu","year":"2018","unstructured":"Xu L, Botchway BO, Zhang S, Zhou J, Liu X (2018a) Inhibition of NF-\u03baB signaling pathway by resveratrol improves spinal cord injury. Front Neurosci 12:690","journal-title":"Front Neurosci"},{"key":"2333_CR133","doi-asserted-by":"publisher","DOI":"10.1177\/1744806918767549","volume":"14","author":"M Xu","year":"2018","unstructured":"Xu M, Cheng Z, Ding Z, Wang Y, Guo Q, Huang C (2018b) Resveratrol enhances IL-4 receptor-mediated anti-inflammatory effects in spinal cord and attenuates neuropathic pain following sciatic nerve injury. Mol Pain 14:1744806918767549","journal-title":"Mol Pain"},{"issue":"3","key":"2333_CR134","doi-asserted-by":"publisher","first-page":"482","DOI":"10.4103\/1673-5374.266064","volume":"15","author":"B-P Xu","year":"2020","unstructured":"Xu B-P et al (2020) Neurological recovery and antioxidant effects of resveratrol in rats with spinal cord injury: a meta-analysis. Neural Regen Res 15(3):482\u2013490","journal-title":"Neural Regen Res"},{"key":"2333_CR135","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainres.2011.09.025","volume":"1423","author":"M Y\u00e1\u00f1ez","year":"2011","unstructured":"Y\u00e1\u00f1ez M, Gal\u00e1n L, Mat\u00edas-Guiu J, Vela A, Guerrero A, Garc\u00eda AG (2011) CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzole. Brain Res 1423:77\u201386","journal-title":"Brain Res"},{"issue":"7","key":"2333_CR136","first-page":"703","volume":"24","author":"Y-B Yang","year":"2003","unstructured":"Yang Y-B, Piao Y-J (2003) Effects of resveratrol on secondary damages after acute spinal cord injury in rats. Acta Pharmacol Sin 24(7):703\u2013710","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"2333_CR137","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.3390\/ijms22094628","volume":"22","author":"AJ Yang","year":"2021","unstructured":"Yang AJ, Bagit A, MacPherson RE (2021) Resveratrol, metabolic dysregulation, and Alzheimer\u2019s disease: considerations for neurogenerative disease. Int J Mol Sci 22(9):4628","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2333_CR138","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1871527317666180425122557","volume":"17","author":"H Yaribeygi","year":"2018","unstructured":"Yaribeygi H, Panahi Y, Javadi B, Sahebkar A (2018) The underlying role of oxidative stress in neurodegeneration: a mechanistic review. CNS Neurol Disord Drug Targets 17(3):207\u2013215","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"2333_CR139","first-page":"155","volume":"14","author":"A Yousaf","year":"2025","unstructured":"Yousaf A, Kabir F, Dalal D, Singh A (2025) Role of calycosin (a derivative of formononetin) in Parkinson\u2019s disease. Lett Appl Nanobiosci 14(3):155","journal-title":"Lett Appl Nanobiosci"},{"key":"2333_CR140","unstructured":"Yousaf A, Singh A, Dalal D (2026) Fisetin as a neuroprotective agent: docking-based modulation of dopaminergic and inflammatory pathways in Parkinson\u2019s disease. Neurophysiology. 1\u201310"},{"issue":"3","key":"2333_CR141","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/08982104.2023.2290050","volume":"34","author":"Y Yu","year":"2024","unstructured":"Yu Y et al (2024) Development of a brain-targeted nano drug delivery system to enhance the treatment of neurodegenerative effects of resveratrol. J Liposome Res 34(3):435\u2013451","journal-title":"J Liposome Res"},{"issue":"1","key":"2333_CR142","first-page":"110","volume":"13","author":"YC Yun","year":"2019","unstructured":"Yun YC, Jeong SG, Kim SH, Cho GW (2019) Reduced sirtuin 1\/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol. J Tissue Eng Regen Med 13(1):110\u2013115","journal-title":"J Tissue Eng Regen Med"},{"issue":"6","key":"2333_CR143","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1007\/s11033-023-08409-1","volume":"50","author":"MY Zamanian","year":"2023","unstructured":"Zamanian MY et al (2023) Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson\u2019s disease: an overview and update on new developments. Mol Biol Rep 50(6):5455\u20135464","journal-title":"Mol Biol Rep"},{"key":"2333_CR144","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3389\/fnins.2017.00611","volume":"11","author":"X Zhang","year":"2017","unstructured":"Zhang X et al (2017) Resveratrol attenuates early brain injury after experimental subarachnoid hemorrhage via inhibition of NLRP3 inflammasome activation. Front Neurosci 11:611","journal-title":"Front Neurosci"},{"issue":"12","key":"2333_CR145","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1039\/C8FO00964C","volume":"9","author":"L-F Zhang","year":"2018","unstructured":"Zhang L-F et al (2018) Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T \u03b1-synuclein mouse model of Parkinson\u2019s disease. Food Funct 9(12):6414\u20136426","journal-title":"Food Funct"},{"issue":"7","key":"2333_CR146","doi-asserted-by":"publisher","first-page":"10659","DOI":"10.18632\/aging.202830","volume":"13","author":"W Zhang","year":"2021","unstructured":"Zhang W, Yu H, Lin Q, Liu X, Cheng Y, Deng B (2021) Anti-inflammatory effect of resveratrol attenuates the severity of diabetic neuropathy by activating the Nrf2 pathway. Aging 13(7):10659","journal-title":"Aging"},{"key":"2333_CR147","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuroscience.2017.02.027","volume":"348","author":"H Zhao","year":"2017","unstructured":"Zhao H et al (2017) Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1\/AMPK signaling pathway. Neuroscience 348:241\u2013251","journal-title":"Neuroscience"},{"key":"2333_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136151","volume":"762","author":"H Zhao","year":"2021","unstructured":"Zhao H, Mei X, Yang D, Tu G (2021) Resveratrol inhibits inflammation after spinal cord injury via SIRT-1\/NF-\u03baB signaling pathway. Neurosci Lett 762:136151","journal-title":"Neurosci Lett"},{"key":"2333_CR149","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jconrel.2022.12.026","volume":"353","author":"X Zheng","year":"2023","unstructured":"Zheng X et al (2023) Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia. J Control Release 353:675\u2013684","journal-title":"J Control Release"},{"issue":"3","key":"2333_CR150","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/mutage\/18.3.287","volume":"18","author":"S Zhou","year":"2003","unstructured":"Zhou S, Kachhap S, Singh KK (2003) Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis 18(3):287\u2013292","journal-title":"Mutagenesis"},{"issue":"1","key":"2333_CR151","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jss.2014.01.062","volume":"189","author":"X-M Zhou","year":"2014","unstructured":"Zhou X-M et al (2014) Resveratrol prevents neuronal apoptosis in an early brain injury model. J Surg Res 189(1):159\u2013165","journal-title":"J Surg Res"},{"issue":"1","key":"2333_CR152","first-page":"7513748","volume":"2018","author":"J Zhou","year":"2018","unstructured":"Zhou J et al (2018) Beneficial effects of resveratrol-mediated inhibition of the mTOR pathway in spinal cord injury. Neural Plast 2018(1):7513748","journal-title":"Neural Plast"},{"issue":"1","key":"2333_CR153","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00210-024-03319-w","volume":"398","author":"L Zhu","year":"2025","unstructured":"Zhu L et al (2025a) Interaction between resveratrol and SIRT1: role in neurodegenerative diseases. Naunyn Schmiedebergs Arch Pharmacol 398(1):89\u2013101","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"2333_CR154","doi-asserted-by":"publisher","DOI":"10.1155\/mi\/4954030","volume":"2025","author":"W Zhu","year":"2025","unstructured":"Zhu W et al (2025b) The chronobiological and neuroprotective mechanisms of resveratrol in improving sleep. Mediators Inflamm 2025(1):4954030","journal-title":"Mediators Inflamm"},{"issue":"2","key":"2333_CR155","first-page":"3212","volume":"17","author":"P Zou","year":"2018","unstructured":"Zou P, Liu X, Li G, Wang Y (2018) Resveratrol pretreatment attenuates traumatic brain injury in rats by suppressing NLRP3 inflammasome activation via SIRT1. Mol Med Rep 17(2):3212\u20133217","journal-title":"Mol Med Rep"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02333-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02333-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02333-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:06:14Z","timestamp":1787929574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02333-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":155,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2333"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02333-z","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}